ABSTRACT
INTRODUCTION
the expensive equipment required for 'true' aerosol exposures, substantial differences in 82 deposition have been noted based on methodology and individual operator (11). Penetration into 83 the alveolar region, in particular, is highly variable and it is unclear whether the liquid delivered 84 with the pathogenic agent might alter lung physiology, further complicating matters. Studies 85 using 'true' aerosols of Ft were employed extensively in the 1950 's, 1960's, and 1970's (12-23) .
86
There has been renewed interest in Ft since the anthrax letters in 2001. In 2012, we showed BHI- of naïve Balb/c mice to lethal doses of LVS. We report here our efforts to develop standardized 93 protocols for aerosol challenge of rabbits and to demonstrate the reproducibility of these 94 protocols. We have previously shown that rabbits are a relevant outbred model of human 95 tularemia (3), with pulmonary architecture similar to human (25). As part of these efforts, we 96 report here that while the choice of culture media for the aerosolized challenge agent did not 97 affect survival of unvaccinated rabbits, it did affect survival of vaccinated rabbits. These latter 98 observations mirror those reported for intranasal challenge of vaccinated inbred mice (26). The 99 implications of these findings and the impact on conducting pivotral vaccine efficacy studies for 100 tularemia and other high-priority, aerosolized agents will be discussed. Rabbits: Young adult male and female New Zealand White (NZW) rabbits (Robinson Services, 113 Inc.) were housed in the University of Pittsburgh RBL at ABSL-3 for the duration of the studies.
MATERIALS & METHODS

102
Biosafety and Regulatory
114
All studies were performed under protocols approved by the University of Pittsburgh's
115
Institutional Animal Care and Use Committee. The University of Pittsburgh is fully accredited 116 by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).
117
Rabbits were monitored at least once daily prior to infection and at least twice daily after 118 infection until clinical signs resolved or the animal became moribund. Prior to vaccination,
119
IPTT-300 temperature/ID chips (BioMedic Data Systems, Seaford, DE) were implanted 120 subcutaneously. Body weight was recorded once in the morning and body temperature was 121 recorded twice daily. Temperature was read using a DAS-7000 reader (BioMedic Data Systems).
122
Rabbits that were determined to be moribund (any of the following clinical signs: weight loss ≥ completed, nebulizer and all-glass impinger (AGI) contents were quantified on CHA.
134
Aerosol exposures: Aerosols of Ft were conducted inside a class III biological safety cabinet
135
(Baker Co., Sanford, ME) located inside the RBL as previously described using the Biaera
136
AeroMP exposure system (Biaera Technologies, Hagerstown, MD) (3). Supplemental Figure 1 137 shows a technical schematic of the aerosol system used for these studies. Rabbits were exposed graphing and statistical analyses were conducted using GraphPad Prism.
RESULTS
162
Environmental data and aerosol particle size
163
During our initial characterization of the aerosol system used for the rabbit studies, we 164 evaluated the environmental conditions inside the rabbit nose-only (RNO) exposure chamber.
165
Supplemental Figure 1A ). Aerosol particle size was 171 measured using 1 µm fluorescein beads as a surrogate and the results are shown in Figure 1B .
172
The mass median aerodynamic diameter (MMAD) of the particles (3.05 µm) was larger than 173 what would be expected for a Collision 3-jet nebulizer although the geometric square deviation 174 of 1.77 suggests a relatively homogeneous particle size as is typical for the Collison (28, 29) .
175
The larger than expected particle size was likely a function of the short distance between the
176
Collison and the RNO exposure chamber and the high RH. However, 80% of the aerosol 177 particles were less than or equal to 5 µm MMAD so they would still be expected to reach the 178 deep lung of the rabbit respiratory tract. Aerosol performance was compared using 'spray factor'
179
(SF), the ratio of the aerosol concentration to the nebulizer concentration. For BHI-grown SCHU 180 S4, SF was higher in the RNO without supplemental humidification compared to BHI-grown
181
SCHU S4 aerosols in a rodent whole-body (RWB) exposure chamber with supplemental 182 humidification ( Figure 1C ). We also evaluated SCHU S4 grown in MHB and found a similar
The SF achieved with MHB-grown SCHU S4 in the RNO was more than a 1-log improvement 185 over MHB-grown SCHU S4 aerosolized into a RWB chamber with supplemental humidification
186
(4.12x10 -7 compared to 2.67x10 -8 , respectively) (24). However, the SF for MHB SCHU S4 in the
187
RNO was still significantly lower than that for BHI SCHU S4 in the RNO (p<0.0001). A higher
188
SF is indicative of better recovery of the agent from an aerosol and a lower nebulizer 189 concentration required to achieve the same desired dose (9, 30).
190
Reproducibility of system performance
191
We next sought to evaluate the variability and reproducibility of the RNO for tularemia 192 aerosols. Figure 2A shows the SF for multiple aerosol exposures ('runs') conducted on 14
193 different days using BHI-grown SCHU S4 with the SF mean across all aerosols (9.48x10-7).
194
One-way ANOVA using Brown-Forsythe's test found that there was a significant difference 195 between means of the different exposure days (p=0.0065)(Supplemental Table 2 ). Tamhane's T2
196 multiple comparisons determined that of the 91 comparisons made between days, significant 197 differences were only found in 12 of those comparisons (Supplemental Table 3 ). We further tularemia vaccine study done in rabbits, the mean inhaled challenge dose (11,070 cfu) delivered 217 to the rabbits was 11-fold higher than the desired target dose of 1,000 cfu ( Figure 4A ). Analysis 218 of the aerosol parameters revealed a 2-fold better than predicted SF (7.8x10 -7 actual vs 4.4x10 -7 219 predicted), but also a nebulizer concentration that was 4-fold higher than desired (9.8x10 5 actual 220 vs 2.4x10 5 desired).
221
Although there was variability in the SF from what we had predicted, the data suggested
222
that a more precise estimation of the nebulizer concentration would improve our accuracy in 223 achieving the target dose. Bacterial concentration in broth culture is often estimated using the 224 optical density (OD) of the culture (for Ft, OD is read at 600 nm) and comparing that with 225 colony growth on agar. Typically, after an 18-hour culture of SCHU S4 in BHI, the OD 600 of the 226 culture is ~0.9. In our determination of the OD to CFU ratio, this was beyond that portion of the 227 curve that was linear, which was between 0.05-0.3 ( Figure 4B & 4C) . We felt that making dilutions of the broth culture to get the OD within that range would produce the desired 229 concentration.
230
In a subsequent repetition of the vaccine study, rabbits were split into 2 doses; one group 231 was to receive 1,000 cfu while the second was to receive 10,000 cfu. Two-fold dilutions were 232 made from the overnight broth culture until the OD 600 fell within the linear range, which was 233 used to then back-calculate the broth culture concentration. For the 1,000 cfu target dose group, 234 the actual mean challenge dose was 1,025 cfu while for the 10,000 cfu target dose group the 235 actual mean challenge dose was 9,038 cfu ( Figure 4D ). For all subsequent vaccine studies, using 236 this refined method for determining the broth culture concentration, challenge doses have 237 averaged 2.6-fold higher than the target dose (Supplemental Figure 2 and Supplemental Table 4 ). shown in Figure 5B and these differences were significant by one-way ANOVA using Brown-
251
Forsythe's test (p<0.0001). In the midst of these studies, we had also evaluated inhalation of 
315
One argument against using the rabbit for tularemia vaccine studies had been that 17, 20, 35, 36) .
321
The data presented here demonstrate that the apparent 'failure' of LVS vaccination in the rabbit survival of LVS-vaccinated rabbits when challenged with ~500 cfu (~25 LD 50 ) MHB-grown 333 SCHU S4, and even those that did survive developed a fever and lost weight post-challenge.
334
However, the severity and duration of both the fever and weight loss seen in LVS-vaccinated 335 rabbits challenged with MHB-grown SCHU S4 was less than that in LVS-vaccinated rabbits 336 challenged with BHI-grown SCHU S4. These data suggest that BHI-grown SCHU S4 is a more 337 rigorous challenge for demonstrating protection in vaccine studies than MHB-grown SCHU S4.
338
Considering that we have previously shown that attenuated derivatives of SCHU S4 outperform
339
LVS and protect rabbits well against both morbidity and mortality at even higher challenge doses show averaged respiratory function for individual rabbits (gray circles) exposed 1, 2 or 3 times to 517 Ft. A) breathing rate, B) tidal volume, C) minute volume in rabbits. There was no significant 518 change in any of the respiratory parameters examined over repeated aerosol exposures. Table 2 . ANOVA analysis of day-to-day variability in tularemia spray factor. dose, in cfu; Actual = averaged actual inhaled dose, in cfu; Fold Difference = difference between 536 actual and target dose; Min = minimum inhaled dose; Max = maximum inhaled dose; CV = 537 coefficient of variation.
SUPPLEMENTAL TABLES
